Upcoming interviews on the 80,000 Hours Podcast

By Robert_Wiblin @ 2019-07-01T14:08 (+25)

Next week I'm interviewing Laura Deming about her work establishing an anti-ageing venture capital fund.

Later this month I'm interviewing Natalie Cargill and Liv Boeree about establishing Effective Giving and their public outreach work promoting EA.

We haven't found a date yet, but I'm also likely to be interviewing the famous cryptography and computer security expert Bruce Schneier about opportunities to do a lot of good through information security careers.

There's always time pressure that prevents us getting to everything we'd like to ask, but feel free to leave a comment below to suggest the questions you'd be interested to hear answered.

For those who missed them, over the last month or two we've put out a number of interviews that are also likely to interest forum contributors:


aarongertler @ 2019-07-02T04:17 (+3)

Rob Wiblin: Are Forum comments fine for submitting questions, or is there another way you'd prefer they be submitted?

Laura Deming: Some question derived from the following cluster:

Liv and Natalie: If you're working with/talking to a potential donor who already has a history of donating heavily to non-EA causes/organizations, how does that change the way you approach your pitch? Do you ever attempt to nudge donors away from organizations they've supported, or is that always a bad idea? (It seems difficult to do this kind of nudge if the donor doesn't initiate it themselves, but nudging successfully could free up millions of dollars in additional funding.)

edoarad @ 2019-07-05T07:55 (+1)

Laura Deming: I'm very interested in the tradeoff and relation between investing more in basic science (with the goal of major theoretical breakthroughs) and developing technology and products (which can have immediate impact but perhaps not as important in the long term).

For example,

1. What is the role of the Academia in progress on aging, as opposed to private research groups? In general, how much resources do they have and what are they incentivized to?

2. What are the current bottlenecks in longevity research and tech?

3. How do you view the market and general public view of longevity in the near future?